Augmentation of Endoxifen Exposure in Tamoxifen-Treated Women Following SSRI Switch

BACKGROUND AND OBJECTIVE: The anti-oestrogen tamoxifen requires metabolic activation to endoxifen by cytochrome P450 (CYP) enzymes, predominantly CYP2D6. Potent CYP2D6-inhibiting antidepressants can seriously disrupt tamoxifen metabolism, probably influencing the efficacy of tamoxifen. For this reas...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Pharmacokinet
Egile Nagusiak: Binkhorst, Lisette, Bannink, Marjolein, de Bruijn, Peter, Ruit, Jan, Droogendijk, Helga, van Alphen, Robbert J., den Boer, Tilly D., Lam, Mei Ho, Jager, Agnes, van Gelder, Teun, Mathijssen, Ron H. J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer International Publishing 2015
Gaiak:
Original Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4756062/
https://ncbi.nlm.nih.gov/pubmed/26446141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-015-0315-x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak